Literature DB >> 27707929

Constitutively Expressed IFITM3 Protein in Human Endothelial Cells Poses an Early Infection Block to Human Influenza Viruses.

Xiangjie Sun1, Hui Zeng1, Amrita Kumar1, Jessica A Belser1, Taronna R Maines1, Terrence M Tumpey2.   

Abstract

A role for pulmonary endothelial cells in the orchestration of cytokine production and leukocyte recruitment during influenza virus infection, leading to severe lung damage, has been recently identified. As the mechanistic pathway for this ability is not fully known, we extended previous studies on influenza virus tropism in cultured human pulmonary endothelial cells. We found that a subset of avian influenza viruses, including potentially pandemic H5N1, H7N9, and H9N2 viruses, could infect human pulmonary endothelial cells (HULEC) with high efficiency compared to human H1N1 or H3N2 viruses. In HULEC, human influenza viruses were capable of binding to host cellular receptors, becoming internalized and initiating hemifusion but failing to uncoat the viral nucleocapsid and to replicate in host nuclei. Unlike numerous cell types, including epithelial cells, we found that pulmonary endothelial cells constitutively express a high level of the restriction protein IFITM3 in endosomal compartments. IFITM3 knockdown by small interfering RNA (siRNA) could partially rescue H1N1 virus infection in HULEC, suggesting IFITM3 proteins were involved in blocking human influenza virus infection in endothelial cells. In contrast, selected avian influenza viruses were able to escape IFITM3 restriction in endothelial cells, possibly by fusing in early endosomes at higher pH or by other, unknown mechanisms. Collectively, our study demonstrates that the human pulmonary endothelium possesses intrinsic immunity to human influenza viruses, in part due to the constitutive expression of IFITM3 proteins. Notably, certain avian influenza viruses have evolved to escape this restriction, possibly contributing to virus-induced pneumonia and severe lung disease in humans. IMPORTANCE: Avian influenza viruses, including H5N1 and H7N9, have been associated with severe respiratory disease and fatal outcomes in humans. Although acute respiratory distress syndrome (ARDS) and progressive pulmonary endothelial damage are known to be present during severe human infections, the role of pulmonary endothelial cells in the pathogenesis of avian influenza virus infections is largely unknown. By comparing human seasonal influenza strains to avian influenza viruses, we provide greater insight into the interaction of influenza virus with human pulmonary endothelial cells. We show that human influenza virus infection is blocked during the early stages of virus entry, which is likely due to the relatively high expression of the host antiviral factors IFITMs (interferon-induced transmembrane proteins) located in membrane-bound compartments inside cells. Overall, this study provides a mechanism by which human endothelial cells limit replication of human influenza virus strains, whereas avian influenza viruses overcome these restriction factors in this cell type.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27707929      PMCID: PMC5126373          DOI: 10.1128/JVI.01254-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: possible involvement in the pathogenesis of human H5N1 virus infection.

Authors:  Hui Zeng; Claudia Pappas; Jessica A Belser; Katherine V Houser; Weiming Zhong; Debra A Wadford; Troy Stevens; Ron Balczon; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Signal transduction and endocytosis: close encounters of many kinds.

Authors:  Alexander Sorkin; Mark Von Zastrow
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

3.  The 2009 pandemic H1N1 and triple-reassortant swine H1N1 influenza viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells.

Authors:  Hui Zeng; Claudia Pappas; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

4.  Effects of receptor binding specificity of avian influenza virus on the human innate immune response.

Authors:  Irene Ramos; Dabeiba Bernal-Rubio; Natasha Durham; Alan Belicha-Villanueva; Anice C Lowen; John Steel; Ana Fernandez-Sesma
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

Review 5.  The pathogenesis of influenza virus infections: the contributions of virus and host factors.

Authors:  Satoshi Fukuyama; Yoshihiro Kawaoka
Journal:  Curr Opin Immunol       Date:  2011-08-11       Impact factor: 7.486

Review 6.  Global alert to avian influenza virus infection: from H5N1 to H7N9.

Authors:  Yong Poovorawan; Sunchai Pyungporn; Slinporn Prachayangprecha; Jarika Makkoch
Journal:  Pathog Glob Health       Date:  2013-07       Impact factor: 2.894

7.  IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.

Authors:  Eric M Feeley; Jennifer S Sims; Sinu P John; Christopher R Chin; Thomas Pertel; Li-Mei Chen; Gaurav D Gaiha; Bethany J Ryan; Ruben O Donis; Stephen J Elledge; Abraham L Brass
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

8.  Mutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may contribute to transmissibility.

Authors:  Holly Shelton; Kim L Roberts; Eleonora Molesti; Nigel Temperton; Wendy S Barclay
Journal:  J Gen Virol       Date:  2013-03-13       Impact factor: 3.891

9.  IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.

Authors:  Tanay M Desai; Mariana Marin; Christopher R Chin; George Savidis; Abraham L Brass; Gregory B Melikyan
Journal:  PLoS Pathog       Date:  2014-04-03       Impact factor: 6.823

Review 10.  Endothelial activation and dysfunction in the pathogenesis of influenza A virus infection.

Authors:  Susan M Armstrong; Ilyse Darwish; Warren L Lee
Journal:  Virulence       Date:  2013-07-17       Impact factor: 5.882

View more
  21 in total

1.  SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.

Authors:  E Kaitlynn Allen; Adrienne G Randolph; Tushar Bhangale; Pranay Dogra; Maikke Ohlson; Christine M Oshansky; Anthony E Zamora; John P Shannon; David Finkelstein; Amy Dressen; John DeVincenzo; Miguela Caniza; Ben Youngblood; Carrie M Rosenberger; Paul G Thomas
Journal:  Nat Med       Date:  2017-07-17       Impact factor: 53.440

2.  HA-Dependent Tropism of H5N1 and H7N9 Influenza Viruses to Human Endothelial Cells Is Determined by Reduced Stability of the HA, Which Allows the Virus To Cope with Inefficient Endosomal Acidification and Constitutively Expressed IFITM3.

Authors:  Luca Hensen; Tatyana Matrosovich; Katrin Roth; Hans-Dieter Klenk; Mikhail Matrosovich
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

3.  Human Interferon Inducible Transmembrane Protein 3 (IFITM3) Inhibits Influenza Virus A Replication and Inflammation by Interacting with ABHD16A.

Authors:  Liang Chen; Limei Zhu; Jun Chen
Journal:  Biomed Res Int       Date:  2021-03-03       Impact factor: 3.411

4.  Site-Specific Lipidation Enhances IFITM3 Membrane Interactions and Antiviral Activity.

Authors:  Emma H Garst; Hwayoung Lee; Tandrila Das; Shibani Bhattacharya; Avital Percher; Rafal Wiewiora; Isaac P Witte; Yumeng Li; Tao Peng; Wonpil Im; Howard C Hang
Journal:  ACS Chem Biol       Date:  2021-04-22       Impact factor: 4.634

5.  Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice.

Authors:  Hui Li; Konrad C Bradley; Jason S Long; Rebecca Frise; Jonathan W Ashcroft; Lorian C Hartgroves; Holly Shelton; Spyridon Makris; Cecilia Johansson; Bin Cao; Wendy S Barclay
Journal:  PLoS Pathog       Date:  2018-01-04       Impact factor: 6.823

6.  SH3GLB2/endophilin B2 regulates lung homeostasis and recovery from severe influenza A virus infection.

Authors:  Kristin K Fino; Linlin Yang; Patricia Silveyra; Sanmei Hu; Todd M Umstead; Susan DiAngelo; E Scott Halstead; Timothy K Cooper; Thomas Abraham; Yoshinori Takahashi; Zhixiang Zhou; Hong Gang Wang; Zissis C Chroneos
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

7.  IFITM3 Rs12252-C Variant Increases Potential Risk for Severe Influenza Virus Infection in Chinese Population.

Authors:  Yang Pan; Peng Yang; Tao Dong; Yi Zhang; Weixian Shi; Xiaomin Peng; Shujuan Cui; Daitao Zhang; Guilan Lu; Yimeng Liu; Shuangsheng Wu; Quanyi Wang
Journal:  Front Cell Infect Microbiol       Date:  2017-06-30       Impact factor: 5.293

Review 8.  Host and viral determinants of influenza A virus species specificity.

Authors:  Jason S Long; Bhakti Mistry; Stuart M Haslam; Wendy S Barclay
Journal:  Nat Rev Microbiol       Date:  2019-01       Impact factor: 60.633

9.  Predicted protein interactions of IFITMs may shed light on mechanisms of Zika virus-induced microcephaly and host invasion.

Authors:  Madhavi K Ganapathiraju; Kalyani B Karunakaran; Josefina Correa-Menéndez
Journal:  F1000Res       Date:  2016-08-05

Review 10.  Host Cell Restriction Factors that Limit Influenza A Infection.

Authors:  Fernando Villalón-Letelier; Andrew G Brooks; Philippa M Saunders; Sarah L Londrigan; Patrick C Reading
Journal:  Viruses       Date:  2017-12-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.